Cargando…
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
OBJECTIVE: This study assessed the incidence of serious adverse events of diabetic ketoacidosis (DKA) among patients with type 2 diabetes treated with canagliflozin. RESEARCH DESIGN AND METHODS: All serious adverse events of DKA and related events (ketoacidosis, metabolic acidosis, and acidosis) fro...
Autores principales: | Erondu, Ngozi, Desai, Mehul, Ways, Kirk, Meininger, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542268/ https://www.ncbi.nlm.nih.gov/pubmed/26203064 http://dx.doi.org/10.2337/dc15-1251 |
Ejemplares similares
-
Neurological Consequences of Diabetic Ketoacidosis at Initial Presentation of Type 1 Diabetes in a Prospective Cohort Study of Children
por: Cameron, Fergus J., et al.
Publicado: (2014) -
Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
por: Ellis, Deborah, et al.
Publicado: (2008) -
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
por: Peters, Anne L., et al.
Publicado: (2015) -
Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?
por: Kitabchi, Abbas E., et al.
Publicado: (2008) -
Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey
por: Hepprich, Matthias, et al.
Publicado: (2023)